跳至主要内容
临床试验/EUCTR2019-003900-10-BE
EUCTR2019-003900-10-BE进行中(未招募)1 期

Pharmacokinetics of intravenous meropenem administered over 12 hours at 2g 3x/d every 6 hours

Cliniques universitaires Saint-Luc0 个研究点目标入组 20 人开始时间: 2019年10月15日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • - Adult > 18 years old (male or female)
  • - non-pregnant woman / breastfeeding
  • - Non-obese (BMI <30)
  • - Normal renal function (clearance >or = 60ml/min)
  • - Requiring meropenem treatment for a bacterial infection requiring a treatment duration of at least 10 days.
  • - The studied dosing regimen will be administered during the non-acute phase of the infection, i.e. 2 days before the planned discontinuation of treatment or discharge of the patient with HAD-OPA.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 16
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 4

排除标准

  • - pregnant woman
  • - creatinine clearance below 60ml/min

研究者

相似试验